358 related articles for article (PubMed ID: 12637469)
1. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.
Batchelor T; Carson K; O'Neill A; Grossman SA; Alavi J; New P; Hochberg F; Priet R
J Clin Oncol; 2003 Mar; 21(6):1044-9. PubMed ID: 12637469
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
5. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma.
O'Brien P; Roos D; Pratt G; Liew K; Barton M; Poulsen M; Olver I; Trotter G
J Clin Oncol; 2000 Feb; 18(3):519-26. PubMed ID: 10653867
[TBL] [Abstract][Full Text] [Related]
6. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas.
Hiraga S; Arita N; Ohnishi T; Kohmura E; Yamamoto K; Oku Y; Taki T; Sato M; Aozasa K; Yoshimine T
J Neurosurg; 1999 Aug; 91(2):221-30. PubMed ID: 10433310
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ;
J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408
[TBL] [Abstract][Full Text] [Related]
8. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
[TBL] [Abstract][Full Text] [Related]
9. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
Herrlinger U; Küker W; Uhl M; Blaicher HP; Karnath HO; Kanz L; Bamberg M; Weller M;
Ann Neurol; 2005 Jun; 57(6):843-7. PubMed ID: 15929034
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.
Zeremski V; Koehler M; Fischer T; Schalk E
Ann Hematol; 2016 Apr; 95(5):793-9. PubMed ID: 26801791
[TBL] [Abstract][Full Text] [Related]
12. [High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute].
Usui N; Dobashi N; Yano S; Yahagi Y; Takei Y; Otsubo H; Takahara S; Yamaguchi Y; Saito T; Minami J; Kamiyama Y; Morikawa N; Machishima T; Osawa H; Aiba K
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1277-82. PubMed ID: 20647709
[TBL] [Abstract][Full Text] [Related]
13. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.
Nguyen PL; Chakravarti A; Finkelstein DM; Hochberg FH; Batchelor TT; Loeffler JS
J Clin Oncol; 2005 Mar; 23(7):1507-13. PubMed ID: 15735126
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
15. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
Blay JY; Conroy T; Chevreau C; Thyss A; Quesnel N; Eghbali H; Bouabdallah R; Coiffier B; Wagner JP; Le Mevel A; Dramais-Marcel D; Baumelou E; Chauvin F; Biron P
J Clin Oncol; 1998 Mar; 16(3):864-71. PubMed ID: 9508167
[TBL] [Abstract][Full Text] [Related]
16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
[TBL] [Abstract][Full Text] [Related]
18. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
Shah GD; Yahalom J; Correa DD; Lai RK; Raizer JJ; Schiff D; LaRocca R; Grant B; DeAngelis LM; Abrey LE
J Clin Oncol; 2007 Oct; 25(30):4730-5. PubMed ID: 17947720
[TBL] [Abstract][Full Text] [Related]
19. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Takeuchi S; Tamura T; Hondoh H; Takahashi H; Onda K; Takahashi H; Tanaka R
Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases.
Gabbai AA; Hochberg FH; Linggood RM; Bashir R; Hotleman K
J Neurosurg; 1989 Feb; 70(2):190-4. PubMed ID: 2913217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
